Obesity is a risk factor for the development of hormone receptorāpositive breast cancer in post-menopausal women. Obesity causes subclinical inflammation in white adipose tissue (WAT), characterized by macrophages surrounding dead or dying adipocytes forming crown-like structures (CLS). Estrogen synthesis is catalyzed by aromatase. Previously, we demonstrated CLS and elevated levels of pro-inflammatory mediators and aromatase in the mammary glands (MG) of obese mice and breast tissue of obese women. Here we tested the hypothesis that supplemental estrogen could prevent or reverse WAT inflammation (WATi) and related molecular changes in the MG. C57BL/6J mice were ovariectomized (OVX) to simulate the post-menopausal state. Supplementation with 17Ī²-estradiol (E2) protected against high fat (HF) diet-induced weight gain and MG WATi. Expression of pro-inflammatory mediators (Cox-2, TNF-Ī±, IL-1Ī²) and aromatase were also reduced in the MG of mice that received supplemental E2. Next, to determine whether E2 supplementation can reverse WATi, obese OVX mice were treated with E2 or placebo and then continued on HF diet. E2 supplementation induced weight loss, reversed MG inflammation and down-regulated expression of pro-inflammatory mediators and aromatase. Finally, we determined whether the protective effects of E2 were mediated by estrogen receptor-Ī± (ERĪ±). Knocking out ERĪ± in ovary intact mice fed a HF diet led to weight gain, WATi and elevated levels of pro-inflammatory mediators and aromatase mimicking the effects of OVX. Taken together, our findings indicate that estrogen via ERĪ± protects against weight gain, WATi and associated increases in pro-inflammatory mediators and aromatase in the MG.